Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm

Figure 6

Drug sensitivity analysis. (a, b) The mutation patterns of BRCA1 and BRCA2 in high- and low-risk groups. (c–i) The IC₅₀ of chemotherapeutic drugs in patients with the high- and low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)